HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis

Modern Pathology

Volumn 22, Issue 9, 2009, Pages 1160-1168

  Stankiewicz, Elzbieta ^a   Kudahetti, Sakunthala C ^a   Prowse, David M ^a   Ktori, Elena ^a   Cuzick, Jack ^a   Ambroisine, Laurence ^a   Zhang, Xiaoxi ^a   Watkin, Nicholas ^b   Corbishley, Catherine ^b   Berney, Daniel M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Human papillomavirus; p16 INK4A; p21; p53; Penile verrucous carcinoma; RB

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CELL CYCLE; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PENIS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SQUAMOUS CELL CARCINOMA; VERRUCOUS CARCINOMA; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, VERRUCOUS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS; POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 69549116612     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.77     Document Type: Article

References (49)

1. Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery 1948;23:670-678.
2. Cuesta KH, Palazzo JP, Mittal KR. Detection of human papillomavirus in verrucous carcinoma from HIV-seropositive patients. J Cutan Pathol 1998;25:165-170.
3. Gualco M, Bonin S, Foglia G, et al. Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinicopathologic entity. Int J Gynecol Cancer 2003;13:317-324. (Pubitemid 38222581)
4. Kraus FT, Perezmesa C. Verrucous carcinoma. Clinical and pathologic study of 105 cases involving oral cavity, larynx and genitalia. Cancer 1966;19:26-38.
5. Cubilla LC, Velazquez EF, Barreto JE, et al. The Penis Sternberg's Diagnostic Surgical Pathology, 4th edn Lippincott Williams & Wilkins: Philadelphia, 2004;pp:2233-2276.
6. Velazquez EF, Cubilla AL. Penile squamous cell carcinoma: anatomic, pathologic and viral studies in Paraguay (1993-2007). Anal Quant Cytol Histol 2007;29:185-198.
7. Cubilla AL. The role of pathologic prognostic factors in squamous cell carcinoma of the penis. World J Urol 2009;27:169-177.
8. Cubilla AL. The penis In: Yong RH, Srigley JR, Amin MB, Ulbright TM and Cubilla AL (eds). Atlas of Tumor Pathology. Tumors of the Prostate Gland, Seminal Vesicles, Male Urethra, and Penis 3rd edn. Armed Forces Institute of Pathology: Washington, DC, 2000, pp 403-475.
9. Narayana AS, Olney LE, Loening SA, et al. Carcinoma of the penis: analysis of 219 cases. Cancer 1982;49:2185-2191.
10. Cubilla AL, Velazques EF, Reuter VE, et al. Warty (condylomatous) squamous cell carcinoma of the penis: a report of 11 cases and proposed classification of 'verruciform' penile tumors. Am J Surg Pathol 2000;24:505-512.
11. Cubilla AL, Reuter V, Velazquez E, et al. Histologic classification of penile carcinoma and its relation to outcome in 61 patients with primary resection. Int J Surg Pathol 2001;9:111-120. (Pubitemid 32619729)
12. Gregoire L, Cubilla AL, Reuter VE, et al. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst 1995;87:1705-1709.
13. Chan KW, Lam KY, Chan AC, et al. Prevalence of human papillomavirus types 16 and 18 in penile carcinoma: a study of 41 cases using PCR. J Clin Pathol 1994;47:823-826.
14. McKee PH, Lowe D, Haigh RJ. Penile verrucous carcinoma. Histopathology 1983;7:897-906.
15. Johnson DE, Lo RK, Srigley J, et al. Verrucous carcinoma of the penis. J Urol 1985;133:216-218.
16. Bunker CB. Topics in penile dermatology. Clin Exp Dermatol 2001;26:469-479.
17. Cubilla AL, Velazquez EF, Young RH. Epithelial lesions associated with invasive penile squamous cell carcinoma: a pathologic study of 288 cases. Int J Surg Pathol 2004;12:351-364.
18. Seixas AL, Ornellas AA, Marota A, et al. Verrucous carcinoma of the penis: retrospective analysis of 32 cases. J Urol 1994;152:1476-1478; discussion 1478-1479. (Pubitemid 24326290)
19. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours 6th edn. Wiley-Liss: New York, 2002, p 239.
20. Prowse DM, Ktori EN, Chandrasekaran D, et al. Human papillomavirus- associated increase in p16INK4A expression in penile lichen sclerosus and squamous cell carcinoma. Br J Dermatol 2008;158:261-265.
21. Noel JC, Vandenbossche M, Peny MO, et al. Verrucous carcinoma of the penis: importance of human papillomavirus typing for diagnosis and therapeutic decision. Eur Urol 1992;22:83-85.
22. Kiyabu MT, Shibata D, Arnheim N, et al. Detection of human papillomavirus in formalin-fixed, invasive squamous carcinomas using the polymerase chain reaction. Am J Surg Pathol 1989;13:221-224. (Pubitemid 19081705)
23. Masih AS, Stoler MH, Farrow GM, et al. Penile verrucous carcinoma: a clinicopathologic, human papillomavirus typing and flow cytometric analysis. Mod Pathol 1992;5:48-55.
24. Pilotti S, Donghi R, D'Amato L, et al. HPV detection and p53 alteration in squamous cell verrucous malignancies of the lower genital tract. Diagn Mol Pathol 1993;2:248-256. (Pubitemid 24001531)
25. Haycox CL, Kuypers J, Krieger JN. Role of human papillomavirus typing in diagnosis and clinical decision making for a giant verrucous genital lesion. Urology 1999;53:627-630. (Pubitemid 29136216)
26. Villa LL, Lopes A. Human papillomavirus DNA sequences in penile carcinomas in Brazil. Int J Cancer 1986;37:853-855. (Pubitemid 16018591)
27. Varma VA, Sanchez-Lanier M, Unger ER, et al. Association of human papillomavirus with penile carcinoma: a study using polymerase chain reaction and in situ hybridization. Hum Pathol 1991;22:908-913.
28. Higgins GD, Uzelin DM, Phillips GE, et al. Differing prevalence of human papillomavirus RNA in penile dysplasias and carcinomas may reflect differing etiologies. Am J Clin Pathol 1992;97:272-278.
29. Senba M, Kumatori A, Fujita S, et al. The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. J Med Virol 2006;78:1341-1346. (Pubitemid 44387519)
30. Lam KY, Chan AC, Chan KW, et al. Expression of p53 and its relationship with human papillomavirus in penile carcinomas. Eur J Surg Oncol 1995;21:613-616.
31. Cupp MR, Malek RS, Goellner JR, et al. The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol 1995;154:1024-1029.
32. Kleter B, van Doorn LJ, ter Schegget J, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998;153:1731-1739. (Pubitemid 28550661)
33. Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001;159:1211-1218. (Pubitemid 32947950)
34. Koyamatsu Y, Yokoyama M, Nakao Y, et al. A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas. Gynecol Oncol 2003;90:547-551.
35. Lam KY, Chan KW. Molecular pathology and clinicopathologic features of penile tumors: with special reference to analyses of p21 and p53 expression and unusual histologic features. Arch Pathol Lab Med 1999;123:895-904.
36. Ouban A, Dellis J, Salup R, et al. Immunohistochemical expression of Mdm2 and p53 in penile verrucous carcinoma. Ann Clin Lab Sci 2003;33:101-106. (Pubitemid 36337006)
37. Adegboyega PA, Boromound N, Freeman DH. Diagnostic utility of cell cycle and apoptosis regulatory proteins in verrucous squamous carcinoma. Appl Immunohistochem Mol Morphol 2005;13:171-177. (Pubitemid 40726855)
38. Hall PA, McCluggage WG. Assessing p53 in clinical contexts: unlearned lessons and new perspectives. J Pathol 2006;208:1-6.
39. Roninson IB. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 2002;179:1-14.
40. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005;24:2899-2908.
41. Missero C, Calautti E, Eckner R, et al. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 1995;92:5451-5455.
42. Cheung TH, Lo KW, Yu MM, et al. Aberrant expression of p21(WAF1/CIP1) and p27(KIP1) in cervical carcinoma. Cancer Lett 2001;172:93-98. (Pubitemid 32823477)
43. Tron VA, Tang L, Yong WP, et al. Differentiation-associated overexpression of the cyclin-dependent kinase inhibitor p21waf-1 in human cutaneous squamous cell carcinoma. Am J Pathol 1996;149:1139-1146. (Pubitemid 26337233)
44. Nevins JR. The Rb/E2F pathway and cancer. Hum Mol Genet 2001;10:699-703.
45. Serrano M. The tumor suppressor protein p16INK4a. Exp Cell Res 1997;237:7-13.
46. Sano T, Oyama T, Kashiwabara K, et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998;153:1741-1748. (Pubitemid 28550662)
47. Ferreux E, Lont AP, Horenblas S, et al. Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol 2003;201:109-118. (Pubitemid 37121209)
48. Dianzani C, Bucci M, Pierangeli A, et al. Association of human papillomavirus type 11 with carcinoma of the penis. Urology 1998;51:1046-1048. (Pubitemid 28240874)
49. Wong M, Walzman M, Zayyan K, et al. Verrucous carcinoma - an embarrassing problem? Int J STD AIDS 2007;18:573-574.